VEXAS syndrome: An update.
Khitri MY, Hadjadj J, Mekinian A, Jachiet V.
Joint Bone Spine. 2024 Jul;91(4):105700. doi: 10.1016/j.jbspin.2024.105700. Epub 2024 Feb 1.
MDS overlap disorders and diagnostic boundaries.
Tanaka TN, Bejar R.
Blood. 2019 Mar 7;133(10):1086-1095. doi: 10.1182/blood-2018-10-844670. Epub 2019 Jan 22.
[VEXAS Syndrome].
Jachiet V, Comont T, Kosmider O, Zhao LP, Mekinian A, Fain O, Hadjadj J.
Rev Prat. 2025 Feb;75(2):196-200.
Juvenile myelomonocytic leukemia.
Proytcheva M.
Semin Diagn Pathol. 2011 Nov;28(4):298-303. doi: 10.1053/j.semdp.2011.08.007.
Diagnostic difficulties in pernicious anemia.
Oo TH.
Discov Med. 2019 Nov-Dec;28(155):247-253.
Bupropion-induced pancytopenia.
Kim JL, Chercover D, Masoudi H, Foltz L.
BMJ Case Rep. 2024 Nov 26;17(11):e262831. doi: 10.1136/bcr-2024-262831.
Schimke Immunoosseous Dysplasia.
Lippner E, Lücke T, Salgado C, Boerkoel C, Lewis DB.
2002 Oct 1 [updated 2023 Mar 30]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
Anemia as the Main Manifestation of Myelodysplastic Syndromes.
Santini V.
Semin Hematol. 2015 Oct;52(4):348-56. doi: 10.1053/j.seminhematol.2015.06.002. Epub 2015 Jun 30.
Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults.
Marchesi RF, Velloso EDRP, Garanito MP, Leal AM, Siqueira SAC, Azevedo Neto RS, Rocha V, Zerbini MCN.
Ann Diagn Pathol. 2020 Apr;45:151459. doi: 10.1016/j.anndiagpath.2019.151459. Epub 2019 Dec 30.
Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management.
Patnaik MM, Tefferi A.
Am J Hematol. 2023 Apr;98(4):681-689. doi: 10.1002/ajh.26828. Epub 2023 Jan 4.
